You have 9 free searches left this month | for more free features.

Condition

Healthy (2)

Coronavirus Disease 2019 (1)

Cutaneous Lupus Erythematosus (1)

Systemic Lupus Erythematosus (1)

Overall Status

Completed (3)

Recruiting (1)

Sign in for free

Phase

phase 1 (3)

phase 2 (1)

Sponsor

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (2)

EMD Serono Research & Development Institute, Inc. (1)

Merck KGaA, Darmstadt, Germany (1)

Collaborator

Merck KGaA, Darmstadt, Germany (1)

Intervention

m5049 (4)

placebo (3)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

m5049

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Healthy Trial in Leeds (M5049)

Completed

Healthy

M5049

Leeds, United Kingdom

Covance Clinical Research Unit Ltd.

Apr 5, 2022

Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus Trial in Worldwide (M5049, Placebo)

Recruiting

Systemic Lupus Erythematosus
Cutaneous Lupus Erythematosus

M5049
Placebo

Pleven, Bulgaria
+10 more

Jul 18, 2022

Coronavirus Disease 2019 Trial in Brazil, Philippines, United States (M5049, Placebo)

Completed

Has Results

Coronavirus Disease 2019

M5049
Placebo

Los Angeles, California
+20 more

May 11, 2022

Healthy Trial in Neu-Ulm (M5049, Placebo)

Completed

Healthy

M5049
Placebo

Neu-Ulm, Germany

Nuvisan GmbH

Dec 2, 2019